Skip to content
Search

Latest Stories

Even mild Covid infection can have detrimental effects on heart health: Study

The study is the first to compare pre and post Covid-infection levels of arterial stiffness which is a marker associated with the ageing and function of our arteries

Even mild Covid infection can have detrimental effects on heart health: Study

A recent study, published in the Journal of Clinical Medicine, warns that even mild cases of Covid-19 can have long-term harmful impacts on cardiovascular health.

The study is the first to compare pre and post-Covid-infection levels of arterial stiffness which is a marker associated with the ageing and function of our arteries.


The findings reveal that individuals with mild Covid-19 experience a decline in artery and central cardiovascular function two to three months after being infected by the disease.

This decline can cause stiffer and more dysfunctional arteries, potentially leading to the development of cardiovascular disease.

"We were surprised to observe such a decline in vascular health, which deteriorated even further with time since Covid-19 infection," stated Maria Perissiou, study co-author from the University of Portsmouth in the UK.

"Usually, you would expect inflammation to decrease with time after infection, and for all the physiological functions to go back to normal or a healthy level," Perissiou said.

According to the researchers, emerging evidence suggests that Covid-19 may trigger an auto-immune process that leads to vasculature deterioration.

Although Covid-19 has been linked to acute heart failure and vascular dysfunction, the long-term impact of the disease on vascular health remains to be explored.

The study, conducted at the University of Split School of Medicine in Croatia, monitored 32 participants between October 2019 and April 2022, most of whom were young, healthy, and under 40 years old.

The study, led by Professor Ana Jeroncic found that only 9 per cent of the participants had high blood pressure, while none had high cholesterol.

Two individuals were diabetic, and the majority (78 per cent) did not smoke. The group was almost evenly divided between males (56 per cent) and females (44 per cent).

Professor Jeroncic stated that, "Given the number of people infected with Covid-19 worldwide, the fact that infection can have harmful effects on cardiovascular health in young people who had a mild form of the disease warrants close monitoring”.

The question of whether the detrimental effect of Covid-19 on cardiovascular health is reversible or permanent, and for how long it persists, was raised by Jeroncic.

The researchers also noted that although the study was small, it does align with the prediction among vascular physiologists that there will be a surge in cardiovascular disease cases in the future due to Covid-19 infections.

However, they emphasised that other contributing factors must also be considered.

(With inputs from PTI)

More For You

Mounjaro price rise

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro

iStock

Mounjaro’s highest dose to rise from £122 to £247.50, not £330

Highlights:

  • Eli Lilly had announced a steep price rise of up to 170% for Mounjaro.
  • A new discount deal with UK suppliers will limit the increase for patients.
  • Pharmacies will still apply a mark-up, but consumer costs are expected to rise less than initially feared.
  • NHS pricing remains unaffected due to separate arrangements.

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro, easing fears of a sharp rise in costs for UK patients. The new arrangement means that, from September, pharmacies and private services will face smaller wholesale increases than first expected, limiting the impact on consumers.

Why the price rise was announced

Earlier this month, Eli Lilly said it would raise Mounjaro’s list price by as much as 170%, which could have pushed the highest monthly dose from £122 to £330. The company argued that UK pricing needed to align more closely with higher costs in Europe and the United States.

Keep ReadingShow less
chicken-pox-istock

The Department of Health said the rollout would reduce missed days at nursery and school, cut time parents take off work, and save the NHS about £15 million a year. (Representational image: iStock)

iStock

England to introduce free chickenpox vaccine for children from 2026

CHILDREN in England will be offered a free chickenpox vaccine for the first time from January 2026, the government has announced.

GP practices will give eligible children a combined vaccine for measles, mumps, rubella and varicella (MMRV) as part of the routine childhood vaccination schedule. Around half a million children each year are expected to be protected.

Keep ReadingShow less
Naga Munchetty urges women to prioritise their health

Naga Munchetty

Naga Munchetty urges women to prioritise their health

WHEN broadcaster and journalist Naga Munchetty began speaking openly about her experiences with adenomyosis and debilitating menstrual pain, the response was overwhelming.

Emails and messages poured in from women who had endured years of dismissal, silence and shame when it came to their health. That outpouring became the driving force behind her new book, It’s Probably Nothing, which calls for women to be heard and to advocate for themselves in a medical system that has too often ignored them.

Keep ReadingShow less
London temple project for Shree Banke Bihari launched

London temple project for Shree Banke Bihari launched

Mahesh Liloriya

The Shree Kunj Bihari Vrindavan (UK) Temple has officially launched its project to establish a grand home for Shree Banke Bihari in London.

The inaugural event, held in Harrow from 4 pm, featured devotional chants, the Deep Pragtya ceremony, and a presentation outlining the temple’s vision. Speaking at the gathering, Shalini Bhargava described the planned temple as “a spiritual home promoting bhakti, unity and seva for generations to come.”

Keep ReadingShow less
Dickie and Watt

Dickie and Watt launched BrewDog at the age of 24

Getty Images

BrewDog co-founder Martin Dickie leaves after 17 years as James Watt steps back

Highlights:

  • Martin Dickie has announced his departure from BrewDog and the alcohol industry.
  • He co-founded the Ellon-based brewer with James Watt in 2007.
  • Dickie cited family time and personal reasons for his exit.
  • His departure follows recent bar closures as part of a company restructuring.
  • BrewDog confirmed no further leadership changes will follow.

BrewDog co-founder Martin Dickie has announced he is leaving the Scottish brewer and the wider alcohol industry for “personal reasons.” Dickie, who founded the Ellon-based business with James Watt in 2007, said he wanted to spend more time with his family after more than two decades in brewing and distilling.

Early beginnings

Dickie and Watt launched BrewDog at the age of 24, starting from a garage in Fraserburgh and selling hand-filled bottles from a van at local markets. The company grew rapidly to become one of the UK’s best-known craft brewers.

Keep ReadingShow less